In a filing, Celldex Therapeutics Inc. revealed its SVP, CHIEF MEDICAL OFFICER Young Diane C. unloaded Company’s shares for reported $1.59 million on Jun 07 ’24. In the deal valued at $35.26 per share,45,000 shares were sold. As a result of this transaction, Young Diane C. now holds 2,115 shares worth roughly $73327.05.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Crowley Elizabeth sold 15,000 shares, generating $525,873 in total proceeds. Upon selling the shares at $35.06, the SR. VP & CPDO now owns 9,074 shares.
Before that, Heath-Chiozzi Margo sold 58,369 shares. Celldex Therapeutics Inc. shares valued at $1,964,088 were divested by the SVP OF REGULATORY AFFAIRS at a price of $33.65 per share. As a result of the transaction, Heath-Chiozzi Margo now holds 13,383 shares, worth roughly $0.46 million.
Wolfe Research initiated its Celldex Therapeutics Inc. [CLDX] rating to an Outperform in a research note published on June 11, 2024; the price target was $51. A number of analysts have revised their coverage, including TD Cowen’s analysts, who began to cover the stock in mid December with a ‘”an Outperform”‘ rating. Wells Fargo also remained covering CLDX and has increased its forecast on November 10, 2023 with a “an Equal weight” recommendation from previously “an Underweight” rating. Wells Fargo started covering the stock on August 22, 2023. It rated CLDX as “an Underweight”.
Price Performance Review of CLDX
On Friday, Celldex Therapeutics Inc. [NASDAQ:CLDX] saw its stock fall -4.83% to $34.67. Over the last five days, the stock has lost -1.73%. Celldex Therapeutics Inc. shares have fallen nearly -12.58% since the year began. Nevertheless, the stocks have fallen -7.79% over the past one year. While a 52-week high of $53.18 was reached on 03/04/24, a 52-week low of $22.11 was recorded on 06/04/24. SMA at 50 days reached $37.81, while 200 days put it at $35.07. A total of 0.69 million shares were traded, compared to the trading of 0.41 million shares in the previous session.
Levels Of Support And Resistance For CLDX Stock
The 24-hour chart illustrates a support level at 34.07, which if violated will result in even more drops to 33.47. On the upside, there is a resistance level at 35.69. A further resistance level may holdings at 36.71. The Relative Strength Index (RSI) on the 14-day chart is 42.40, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.17, which suggests price will go up in the next trading period. Percent R suggests that price movement has been low at 55.35%. Stochastics %K at 59.70% indicates the stock is a holding.
The most recent change occurred on September 17, 2021 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $66 price target.
